In vitro diagnostic testing for drug allergy in children

F Saretta, L Tomei, F Mori… - Pediatric Allergy and …, 2023 - Wiley Online Library
Abstract Diagnosing Drug Hypersensitivity Reactions (DHRs) could be a complicated
process especially in children, since allergic‐like manifestation at this age is more often the …

Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin Disorders

A Sernicola, R Mazzetto, J Tartaglia, C Ciolfi, P Miceli… - Medicina, 2023 - mdpi.com
HLA class II molecules are key factors determining susceptibility to autoimmune disorders,
and their role in immune-mediated skin conditions such as psoriasis has been extensively …

Pemphigus‐und Pemphigoid‐Erkrankungen: Klinik, Diagnostik und Therapie: Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy

D Didona, MF Schmidt, R Maglie… - JDDG: Journal der …, 2023 - Wiley Online Library
Pemphigus und Pemphigoid sind seltene Autoimmunkrankheiten der Haut mit potenziell
lebensbedrohlichem Verlauf. Autoantikörper gegen epidermale und junktionale …

[HTML][HTML] Successful treatment of linear immunoglobulin A bullous dermatosis with dupilumab in a pediatric patient

N Almuhanna, R Alhamazani, S Alkhezzi, MT Alfataih… - JAAD Case Reports, 2023 - Elsevier
Discussion Due to its rarity and lack of Food and Drug Administration approved treatment,
LABD in children is difficult to treat. Systemic dapsone is the most common first-line …

[HTML][HTML] Linear IgA bullous dermatosis: 32 years of experience

T Atci, GP Ulutas, EG Sirkeci, R Küçükoğlu - Anais Brasileiros de …, 2024 - Elsevier
Abstract Background Linear IgA bullous dermatosis (LABD) is an uncommon disease with
only a few reported studies in large series with long follow-up periods. Objectives To …

[HTML][HTML] Treatment of chronic bullous disease of childhood with dupilumab after dapsone-induced methemoglobinemia in a 2-year-old female patient

F Yousefian, FZ Deligonul, L Swanson - JAAD Case Reports, 2023 - ncbi.nlm.nih.gov
Treatment of chronic bullous disease of childhood with dupilumab after dapsone-induced
methemoglobinemia in a 2-year-old female patient - PMC Back to Top Skip to main content NIH …

Letter in reply: Linear IgA bullous dermatosis treated with dupilumab in a pediatric patient with glucose-6-phosphate dehydrogenase deficiency

S Muzumdar, LA Bibb, B Sloan, M Murphy… - JAAD Case …, 2024 - jaadcasereports.org
Fig 1. Before dupilumab therapy, the patient had (A) vesicles and eroded papules on the
bilateral cheeks and (B) bullae in a ''crown of jewels''distribution on the legs. After 6 months …

[PDF][PDF] Linear IgA bullous dermatosis in a latin adolescent treated with cyclosporine and prednisone

A Ríos-Sánchez, JA Godínez-Chaparro… - Boletin medico del …, 2024 - researchgate.net
Abstract Introduction: Linear IgA bullous dermatosis (LABD) is a rare autoimmune disease.
Although dapsone is the initial treatment, other immunomodulators are used in resistant …

[HTML][HTML] Metronidazole-induced linear immunoglobulin A disease in a patient suffering from ulcerative colitis: a case report and focused review of the literature

S Buffon, M Parietti, A Carugno, ER Test… - Dermatology …, 2023 - pmc.ncbi.nlm.nih.gov
Linear immunoglobulin (Ig) A disease (LAD) is a rare autoimmune blistering dermatosis
caused by linear deposition of IgA1 along the dermoepidermal junction of skin and …

Annular bullous lesions in a child from Uganda: chronic bullous disease of childhood

AB Ambur, TA Nyckowski, A Bhukhan - Journal of Osteopathic …, 2023 - degruyter.com
A 10-year-old male presented to our global outreach clinic in Uganda in May 2018 with a
recurrent pruritic blistering rash on the lower leg of 1 year in duration. His medical history …